The DOI matches its Crossref record; 293 of the 294 references it cites were found in a registry or an index.
Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs
Open accessAbstract
Here, we discuss the principles of allosteric activating mutations, propagation downstream of the signals that they prompt, and allosteric drugs, with examples from the Ras signaling network. We focus on Abl kinase where mutations shift the landscape toward the active, imatinib binding-incompetent conformation, likely resulting in the high affinity ATP outcompeting drug binding. Recent pharmacological innovation extends to allosteric inhibitor (GNF-5)-linked PROTAC, targeting Bcr-Abl1 myristoylation site, and broadly, allosteric heterobifunctional degraders that destroy targets, rather than inhibiting them. Designed chemical linkers in bifunctional degraders can connect the allosteric ligand that binds the target protein and the E3 ubiquitin ligase warhead anchor. The physical properties and favored conformational state of the engineered linker can precisely coordinate the distance and orientation between the target and the recruited E3. Allosteric PROTACs, noncompetitive molecular glues, and bitopic ligands, with covalent links of allosteric ligands and orthosteric warheads, increase the effective local concentration of productively oriented and placed ligands. Through covalent chemical or peptide linkers, allosteric drugs can collaborate with competitive drugs, degrader anchors, or other molecules of choice, driving innovative drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Due to its higher specificity and consequently lower toxicity, which results from targeting nonconserved allosteric sites, allostery also increasingly features in allosteric drugs.”
From AlphaFold, Artificial Intelligence (AI), and Allostery (2022) · cites this paper as [121]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–293 of 293
Stetz, G., Tse, A., & Verkhivker, G. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25329-4 · Cited by 50
Exploring the Allosteric Territory of Protein Function
Tee, W.-V., Tan, Z. W., Lee, K., Guarnera, E., & Berezovsky, I. N. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c00540 · Cited by 50
Alvarez-Benayas, J., Trasanidis, N., Katsarou, A., Ponnusamy, K., Chaidos, A., May, P. C., Xiao, X., Bua, M., Atta, M. L. B. S., Roberts, I. A. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25704-2 · Cited by 50
Šolman, M., Ligabue, A., Blaževitš, O., Jaiswal, A., Zhou, Y., Hong, L., Lectez, B. L. P., Kopra, K., Guzmán, C., Härmä, H., et al. (2015) · eLife · doi:10.7554/elife.08905 · Cited by 48
Kannan, S., Venkatachalam, G., Lim, H. H., Surana, U., & Verma, C. S. (2018) · Chemical Science · doi:10.1039/c8sc01262h · Cited by 48
Allosteric inhibition explained through conformational ensembles sampling distinct “mixed” states
Byun, J. A., VanSchouwen, B., Akimoto, M., & Melacini, G. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.10.026 · Cited by 48
Structurally distributed surface sites tune allosteric regulation
McCormick, J. W., Russo, M. A., Thompson, S., Blevins, A., & Reynolds, K. A. (2021) · eLife · doi:10.7554/elife.68346 · Cited by 48
Tsai, C., & Nussinov, R. (2014) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp54253j · Cited by 47
Self-citationSmith, I. N., Thacker, S., Jaini, R., & Eng, C. (2018) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2018.1465854 · Cited by 47
Nussinov, R., Zhang, M., Tsai, C., Liao, T.-J., Fushman, D., & Jang, H. (2018) · Biophysical Reviews · doi:10.1007/s12551-018-0461-0 · Cited by 47
Self-citationWhy Are Some Driver Mutations Rare?
Nussinov, R., Tsai, C., & Jang, H. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.10.003 · Cited by 47
Self-citationPhosphorylation and Driver Mutations in PI3Kα and PTEN Autoinhibition
Nussinov, R., Zhang, M., Tsai, C., & Jang, H. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0818 · Cited by 46
Self-citationAllostery, and how to define and measure signal transduction
Nussinov, R., Tsai, C., & Jang, H. (2022) · Biophysical Chemistry · doi:10.1016/j.bpc.2022.106766 · Cited by 46
Self-citationGul, A., Leyland-Jones, B., Dey, N., & De, P. K. (2018) · Europe PMC (PubMed Central) · Cited by 45
Markov state models and NMR uncover an overlooked allosteric loop in p53
de Barros, E. P., Demir, Ö., Soto, J., Cocco, M. J., & Amaro, R. E. (2020) · Chemical Science · doi:10.1039/d0sc05053a · Cited by 45
Gupta, A. K., Wang, X., Pagba, C. V., Prakash, P., Sarkar‐Banerjee, S., Putkey, J. A., & Gorfe, A. A. (2019) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13519 · Cited by 43
Nussinov, R., Tsai, C., & Jang, H. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.002 · Cited by 42
Self-citationPI3K Driver Mutations: A Biophysical Membrane-Centric Perspective
Zhang, M., Jang, H., & Nussinov, R. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0911 · Cited by 42
Self-citationEmerging Trends in Cancer Drug Discovery—From Drugging the “Undruggable” to Overcoming Resistance
Rudolph, J., Settleman, J., & Malek, S. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0260 · Cited by 42
Structural snapshots of RAF kinase interactions
Adariani, S. R., Buchholzer, M., Akbarzadeh, M., Nakhaei‐Rad, S., Dvorský, R., & Ahmadian, M. R. (2018) · Biochemical Society Transactions · doi:10.1042/bst20170528 · Cited by 41
AlloDriver: a method for the identification and analysis of cancer driver targets
Song, K., Li, Q., Gao, W., Lu, S., Shen, Q., Liu, X., Wu, Y., Wang, B., Lin, H., Chen, G., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz350 · Cited by 41
Allosteric conformational ensembles have unlimited capacity for integrating information
Biddle, J. W., Martinez-Corral, R., Wong, F., & Gunawardena, J. (2021) · eLife · doi:10.7554/elife.65498 · Cited by 41
Ras assemblies and signaling at the membrane
Nussinov, R., Tsai, C., & Jang, H. (2020) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2020.01.009 · Cited by 40
Self-citationPosttranslational Regulation and Conformational Plasticity of PTENPreprint
Kotelevets, L., Trifault, B., Chastre, E., & Scott, M. G. H. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036095 · Cited by 40
Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt
de Vries, R. M. J. M., Meijer, F. A., Doveston, R. G., Leijten-van de Gevel, I. A., & Brunsveld, L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2021287118 · Cited by 38
Kinase-Independent Mechanisms of Resistance of Leukemia Stem Cells to Tyrosine Kinase Inhibitors
Ichim, C. V. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2012-0159 · Cited by 36
Recognition of protein allosteric states and residues: Machine learning approaches
Zhou, H.-Y., Dong, Z., & Tao, P. (2018) · Journal of Computational Chemistry · doi:10.1002/jcc.25218 · Cited by 36
Liao, T.-J., Jang, H., Nussinov, R., & Fushman, D. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.9b10710 · Cited by 36
Self-citationNussinov, R., Jang, H., Tsai, C., & Cheng, F. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007114 · Cited by 36
Self-citationGene-specific transcription activation via long-range allosteric shape-shifting
Tsai, C., & Nussinov, R. (2011) · Biochemical Journal · doi:10.1042/bj20110972 · Cited by 35
Self-citationAutoinhibition can identify rare driver mutations and advise pharmacology
Nussinov, R., Tsai, C., & Jang, H. (2019) · The FASEB Journal · doi:10.1096/fj.201901341r · Cited by 35
Self-citationActivity-Dependent Gene Expression in Neurons
Lee, P. R., & Fields, R. D. (2020) · The Neuroscientist · doi:10.1177/1073858420943515 · Cited by 35
Allosteric KRas4B Can Modulate SOS1 Fast and Slow Ras Activation Cycles
Liao, T.-J., Jang, H., Fushman, D., & Nussinov, R. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2018.07.016 · Cited by 34
Self-citationLechtenberg, B. C., Gehring, M. P., Light, T. P., Horne, C. R., Matsumoto, M. W., Hristova, K. A., & Pasquale, E. B. (2021) · Nature Communications · doi:10.1038/s41467-021-27343-z · Cited by 33
A Conserved Activation Cluster Is Required for Allosteric Communication in HtrA-Family Proteases
de Regt, A. K., Kim, S., Sohn, J., Grant, R. A., Baker, T. A., & Sauer, R. T. (2015) · Structure · doi:10.1016/j.str.2015.01.012 · Cited by 32
Ferraro, M., Moroni, E., Ippoliti, E., Rinaldi, S., Sànchez‐Martìn, C., Rasola, A., Pavarino, L. F., & Colombo, G. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c09742 · Cited by 32
Free Energy Diagrams for Protein Function
Nussinov, R., & Tsai, C. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.015 · Cited by 31
Self-citationKinact: a computational approach for predicting activating missense mutations in protein kinases
Rodrigues, C. H., Ascher, D. B., & Pires, D. E. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky375 · Cited by 31
Protein Structural Information and Evolutionary Landscape by In Vitro Evolution
Fantini, M., Lisi, S., Rios, P. D. L., Cattaneo, A., & Pastore, A. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz256 · Cited by 30
Allosteric Inhibition of ABL Kinases: Therapeutic Potential in Cancer
Jones, J. K., & Thompson, E. M. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0069 · Cited by 30
Unifying Catalysis Framework to Dissect Proteasomal Degradation Paradigms
Rodriguez-Rivera, F. P., & Levi, S. M. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00389 · Cited by 30
St‐Cyr, D. J., Ceccarelli, D. F. J., Orlicky, S. M., van der Sloot, A. M., Tang, X., Kelso, S., Moore, S., James, C. A., Posternak, G., Coulombe‐Huntington, J., et al. (2021) · Science Advances · doi:10.1126/sciadv.abi5797 · Cited by 30
Inhibition of Nonfunctional Ras
Nussinov, R., Jang, H., Gürsoy, A., Keskin, Ö., & Gaponenko, V. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2020.12.012 · Cited by 29
Self-citationRas isoform-specific expression, chromatin accessibility, and signaling
Nussinov, R., Zhang, M., Maloney, R., & Jang, H. (2021) · Biophysical Reviews · doi:10.1007/s12551-021-00817-6 · Cited by 29
Self-citationAllosteric activation of RAF in the MAPK signaling pathway
Tsai, C., & Nussinov, R. (2018) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2018.07.007 · Cited by 27
Self-citationInhibiting the RAS–PI3K Pathway in Cancer Therapy
Sheridan, C., & Downward, J. (2013) · The Enzymes · doi:10.1016/b978-0-12-420146-0.00005-6 · Cited by 25
Oncogenic KRas mobility in the membrane and signaling response
Nussinov, R., Tsai, C., & Jang, H. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.009 · Cited by 25
Self-citationVerkhivker, G. M. (2018) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2018.10.009 · Cited by 25
Identifying modules of cooperating cancer drivers
Klein, M., Cannataro, V. L., Townsend, J. P., Newman, S., Stern, D. F., & Zhao, H. (2021) · Molecular Systems Biology · doi:10.15252/msb.20209810 · Cited by 25
Estimating the cooperativity of PROTAC-induced ternary complexes using 19 F NMR displacement assay
Castro, G. V., & Ciulli, A. (2021) · RSC Medicinal Chemistry · doi:10.1039/d1md00215e · Cited by 25
Astl, L., & Verkhivker, G. M. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b01045 · Cited by 24
Deep phylogeny of cancer drivers and compensatory mutations
Rochman, N. D., Wolf, Y. I., & Koonin, E. V. (2020) · Communications Biology · doi:10.1038/s42003-020-01276-7 · Cited by 24
Imatinib can act as an Allosteric Activator of Abl Kinase
Xie, T., Saleh, T., Rossi, P., Miller, D. J., & Kalodimos, C. G. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167349 · Cited by 24
Šoštarić, N., & van Noort, V. (2021) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1008988 · Cited by 23
Liu, H., & Liu, R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bby123 · Cited by 22
Zhou, Y., Zhao, J., Fang, J., Martin, W., Li, L., Nussinov, R., Chan, T. A.-T., Eng, C., & Cheng, F. (2021) · Genome biology · doi:10.1186/s13059-021-02269-3 · Cited by 22
Self-citationLuttman, J. H., Hoj, J. P., Lin, K., Lin, J., Gu, J., Rouse, C., Nichols, A., MacIver, N. J., Wood, K. C., & Pendergast, A. M. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109880 · Cited by 22
Astl, L., & Verkhivker, G. M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.07.008 · Cited by 21
Agajanian, S., Odeyemi, O., Bischoff, N., Ratra, S., & Verkhivker, G. M. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00414 · Cited by 20
Zhang, L., Li, M., & Liu, Z. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006393 · Cited by 20
Oncogenic K-Ras4B Dimerization Enhances Downstream Mitogen-activated Protein Kinase Signaling
Muratcioğlu, S., Aydın, C., Odabasi, E., Özdemir, E. S., Firat‐Karalar, E. N., Jang, H., Tsai, C., Nussinov, R., Kavaklı, İ. H., Gürsoy, A., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.002 · Cited by 19
Self-citationBiasing conformational ensembles towards bioactive-like conformers for ligand-based drug design
Musafia, B., & Senderowitz, H. (2010) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2010.513711 · Cited by 18
Kenakin, T. (2012) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2012.07.006 · Cited by 18
Dynamic Protein Allosteric Regulation and Disease
Nussinov, R., Tsai, C.-J., & Jang, H. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-981-13-8719-7_2 · Cited by 18
Self-citationOrthosteric and Allosteric Dual Targeting of the Nuclear Receptor RORγt with a Bitopic Ligand
Meijer, F. A., Oerlemans, G. J. M., & Brunsveld, L. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00941 · Cited by 18
Catala, A., & Ahmad, U. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89926 · Cited by 18
Maeda, Y., Tidyman, W. E., Ander, B. P., Pritchard, C. A., & Rauen, K. A. (2021) · Developmental Dynamics · doi:10.1002/dvdy.309 · Cited by 17
Relationship between regulatory pattern of gene expression level and gene function
Inoue, M., & Horimoto, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177430 · Cited by 16
Driver mutations in oncogenesis
Morjaria, S. (2020) · International Journal of Molecular and Immuno Oncology · doi:10.25259/ijmio_26_2020 · Cited by 16
Alaalm, L., Crunden, J. L., Butcher, M. C., Obst, U., Whealy, R. N., Williamson, C. E., O’Brien, H., Schaffitzel, C., Ramage, G., SPENCER, J. M., et al. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.637836 · Cited by 16
Meijer, F. A., van den Oetelaar, M. C. M., Doveston, R. G., Sampers, E. N. R., & Brunsveld, L. (2021) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.1c00029 · Cited by 15
Nikanjam, M., Tinajero, J., Barkauskas, D. A., & Kurzrock, R. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0861 · Cited by 15
Das, J. K., Thakuri, B., MohanKumar, K., Roy, S., Sljoka, A., Sun, G., & Chakraborty, A. (2021) · ACS Omega · doi:10.1021/acsomega.1c05155 · Cited by 15
Drugging multiple same-allele driver mutations in cancer
Nussinov, R., Zhang, M., Maloney, R., & Jang, H. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1905628 · Cited by 14
Self-citationCoNSEnsX: an ensemble view of protein structures and NMR-derived experimental data
Ángyán, A. F., Szappanos, B., Perczel, A., & Gáspári, Z. (2010) · BMC Structural Biology · doi:10.1186/1472-6807-10-39 · Cited by 13
Allosteric therapies for lung cancer
Ye, L., Jing, M., & Wang, X. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-015-9567-z · Cited by 12
Localization of Energetic Frustration in Proteins
Guzovsky, A. B., Schafer, N. P., Wolynes, P. G., & Ferreiro, D. U. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1716-8_22 · Cited by 12
Approach in Improving Potency and Selectivity of Kinase Inhibitors: Allosteric Kinase Inhibitors
Wei, S., Zhao, T., Wang, J., & Zhai, X. (2020) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666201222144355 · Cited by 12
Wang, T., Song, J., Qu, M., Gao, X., Zhang, W., Wang, Z., Zhao, L., Wang, Y., Li, B., Li, J., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.723676 · Cited by 12
O’Rourke, K. F., D’Amico, R. N., Sahu, D., & Boehr, D. D. (2020) · Protein Science · doi:10.1002/pro.4011 · Cited by 11
2016 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference
Barzaghi, F., Passerini, L., Sartirana, C., Bejerano, G., Floris, M., Cesaro, S., Cimaz, R., Roncarolo, M. G., Santini, F., Goldbach‐Mansky, R. T., et al. (2016) · Journal of Clinical Immunology · doi:10.1007/s10875-016-0237-x · Cited by 10
Allosteric Modulators for GPCRs as a Therapeutic Alternative with High Potential in Drug Discovery
Reyes‐Alcaraz, A., Garcia-Rojas, E. Y. L., Bond, R. A., & McConnell, B. K. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.91838 · Cited by 10
Moisoiu, V., Teodorescu, P., Parajdi, L. G., Paşca, S., Zdrenghea, M., Dima, D. M., Precup, R., Tomuleasa, C., & Soverini, S. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00863 · Cited by 9
Presence or Absence of Ras Dimerization Shows Distinct Kinetic Signature in Ras-Raf Interaction
Sarkar, S., & Garcı́a, A. E. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.03.004 · Cited by 9
Li, R., Grimm, S. A., & Wade, P. A. (2021) · STAR Protocols · doi:10.1016/j.xpro.2021.100764 · Cited by 9
Dynamics of Post-Translational Modification Inspires Drug Design in the Kinase Family.
Zhang, H., He, J.-X., Hu, G., Zhu, F., Jiang, H., Gao, J., Zhou, H., Lin, H., Wang, Y.-J., Chen, K.-F., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01076 · Cited by 9
Gaalswyk, K., Liu, Z., Vogel, H. J., & MacCallum, J. L. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.676268 · Cited by 7
Gui, Y., Grzyb, K., Thomas, M. H., Ohnmacht, J., Garcia, P., Buttini, M., Skupin, A., Sauter, T., & Sinkkonen, L. (2021) · Epigenetics & Chromatin · doi:10.1186/s13072-021-00418-3 · Cited by 7
Pons, T., Chinea, G., Olmea, O., Beldarraı́n, A., Roca, H., Padrón, G., & Valencia, A. (1998) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19980601)31:4 · Cited by 6
Self-citationQuaglia, F., Lázár, T., Hatos, A., Tompa, P., Piovesan, D., & Tosatto, S. C. E. (2021) · Current Protocols · doi:10.1002/cpz1.192 · Cited by 5
Editorial overview: Catalysis and regulation: The beating heart of biology
Nussinov, R., & Shirouzu, M. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.09.002 · Cited by 3
Self-citationIn Silico Modeling and Scoring of PROTAC-Mediated Ternary Complex Poses
Liao, J., Nie, X., Unarta, I., Ericksen, S., & Tang, W. (2021) · doi:10.26434/chemrxiv-2021-ldzzz-v2 · Cited by 2
Armstrong, S. A., Malley, R., & Weinberg, B. A. (2020) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2020.16.1.31 · Cited by 1
Flagged first, then by citations
1 of the 294 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
AlphaFold, Artificial Intelligence (AI), and Allostery
Nussinov, R., Zhang, M., Liu, Y., & Jang, H. (2022) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.2c04346 · Cited by 190
Self-citationProtein conformational ensembles in function: roles and mechanisms
Nussinov, R., Liu, Y., Zhang, W., & Jang, H. (2023) · RSC Chemical Biology · doi:10.1039/d3cb00114h · Cited by 118
Self-citationLigand discovery by activity-based protein profiling
Niphakis, M. J., & Cravatt, B. F. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.08.006 · Cited by 91
Molecular glues and induced proximity: An evolution of tools and discovery
Robinson, S. A., Co, J., & Banik, S. M. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.04.001 · Cited by 56
Allosteric drugs: New principles and design approaches
Tee, W.-V., & Berezovsky, I. N. (2024) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102758 · Cited by 54
Metadata
- Authors
- Nussinov, R., Zhang, M., Maloney, R., Liu, Y., Tsai, C.-J., & Jang, H.
- Affiliations
- Tel Aviv University (IL)
- Frederick National Laboratory for Cancer Research (US)
- Corresponding author
- Nussinov, Ruth
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2022-09
- Volume
- 434
- Issue
- 17
- Pages
- 167569
- ISSN
- 0022-2836 (ISSN-L)
- PMC
- PMC9398924
- OpenAlex
- W4220688241
- Cited by
- 66
- References
- 294
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 12 · 2023: 11 · 2022: 9
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Molecular Biology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Frederick National Laboratory for Cancer Research
- National Institutes of Health (HHSN261201500003I)
- U.S. Department of Health and Human Services
- National Cancer Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- Ras signaling, c-Abl, PROTACs, chemical linkers, E3 ubiquitin ligase, molecular glues, bitopic ligands, drug discovery
- MeSH terms
- Allosteric Regulation, Antineoplastic Agents, Humans, Ligands, Mutation, Neoplasms, Fusion Proteins, bcr-abl, Protein Kinase Inhibitors, Drug Discovery, Proteolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
